Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 손경식, 제일제당 주식회사filedCritical손경식
Priority to KR1019960001357ApriorityCriticalpatent/KR970058712A/en
Publication of KR970058712ApublicationCriticalpatent/KR970058712A/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
본 발명은 하기 구조식(@)로 표시되는 위산분비 억제제를 함유한 주사용 제제에 관한 것이다.The present invention relates to a injectable preparation containing a gastric acid secretion inhibitor represented by the following structural formula (@).
Description
새로운 위산분비 억제제를 함유한 주사용제제Injectable preparations containing a new inhibitor of gastric acid secretion
내용없음No content
Claims (3)
하기 구조식(Ⅰ)로 표시되는 위산분비억제제인 [[[2-[(디아미노메틸렌)아미노]-4-티아졸릴]메틸]티오]-N2-설파모일프로피온아미딘과, 5-옥소테트라하이드로퓨란-2-카르복실산을 함유하는 것을 특징으로하는 주사용 제제.[2 - [(diaminomethylene) amino] -4-thiazolyl] methyl] thio] -N2-sulfamoylpropionamidine, which is a gastric acid secretion inhibitor represented by the following structural formula (I) and 5-oxotetrahydro Furan-2-carboxylic acid.제1항에 있어서, [[[2-[(디아미노메틸렌)아미노]-4-티아졸릴]메틸]티오]-N2-설파모일프로피온아미딘 0.01~10W/V% 및 5-옥소테트라하이드로퓨란-2-카르복실산 0.01~10W/V%를 함유하는 것을 특징으로 하는 주사용 제제.2. The method of claim 1, wherein 0.01 to 10 W / V% of [[2- [(diaminomethylene) amino] -4-thiazolyl] methyl] thio] -N2-sulfamoylpropionamidine and 5-oxotetrahydrofuran -2-carboxylic acid in an amount of 0.01 to 10 W / V%.제1항 또는 제2항에 있어서, 만니톨, 솔비톨 등이 다가알코올을 0.1~10W/V% 함유하는 것을 특징으로 하는 주사용 제제.The injectable preparation according to any one of claims 1 to 3, wherein mannitol, sorbitol, etc. contain 0.1 to 10 W / V% of a polyhydric alcohol.※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.※ Note: It is disclosed by the contents of the first application.
KR1019960001357A1996-01-231996-01-23
Injectable preparations containing a new inhibitor of gastric acid secretion
KR970058712A
(en)
Process for producing 7-/3-aryl-1-piperazinyl/- and 7-/3-cyclohexyl-1-piperazinyl/-3-quinoline-carboxylic acids and pharmaceutical compositions containing them as active agents
DERIVATIVES 2-AMINO-N - [[[4- (AMINOCARBONIL) PYRIMIDIN-2-IL] AMINO] ALKYL] PYRIMIDIN-4-CARBOXAMIDE, METHOD FOR THEIR PRODUCTION AND PHARMACEUTICAL COMPOSITION